SEARCH

SEARCH BY CITATION

References

  • Aparicio, J.F., Caffrey, P., Gil, J.A. and Zotchev, S.B. (2003) Polyene antibiotic biosynthesis gene clusters. Appl Microbiol Biotechnol 61, 179188.
  • Aparicio, J.F., Mendes, M.V., Anton, N., Recio, E. and Martin, J.F. (2004) Polyene macrolide antibiotic biosynthesis. Current Med Chem 11, 16451656.
  • Arikan, S., Ostrosky-Zeichner, L., Lozano-Chiu, M., Paetznick, V., Gordon, D., Wallace, T. and Rex, J.H. (2002) In vitro activity of nystatin compared with those of liposomal nystatin, amphotericin B, and fluconazole against clinical Candida isolates. J Clin Microbiol 40, 14061412.
  • Bolard, J. (1986) How do the polyene macrolide antibiotics affect the cellular membrane properties? Biochim Biophys Acta 864, 257304.
  • Brock, T.D. (1956) The effect of oils and fatty acids on the production of filipin. Appl Environ Microbiol 4, 131133.
  • Carrillo-Munoz, A.J., Quindos, G., Tur, C., Ruesga, M.T., Miranda, Y., del Valle, O., Cossum, P.A. and Wallace, T.L. (1999) In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole. J Antimicrob Chemother 44, 397401.
  • Cohen, B.E. (2010) Amphotericin B membrane action: role for two types of ion channels in eliciting cell survival and lethal effects. J Membr Biol 238, 120.
  • Dutcher, J.D., Gold, W., Pagano, J.F. and Vanderputte, J. (1959) Amphotericin B, its production, and its salts. USA Patent, 2908611.
  • EUCAST (2003) Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. Clin Microbiol Infect 9, ixxv.
  • EUCAST (2010) Amphotericin B: Rationale for the EUCAST clinical breakpoints, version 1.0.7.
  • Fischbach, M.A. and Walsh, C.T. (2006) Assembly-line enzymology for polyketide and nonribosomal peptide antibiotics: logic, machinery, and mechanisms. Chem Rev 106, 34683496.
  • Frykman, S., Tsuruta, H. and Licari, P. (2005) Assessment of fed-batch, semicontinuous, and continuous epothilone D production processes. Biotechnol Prog 21, 11021108.
  • Georgopapadakou, N.H. (1998) Antifungals: mechanism of action and resistance established, and novel drugs. Curr Opin Microbiol 1, 547557.
  • Ghannoum, M.A. and Rice, L.B. (1999) Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 12, 501517.
  • Gil, J., Naharro, G., Villanueva, J. and Martin, J. (1985) Characterization and regulation of p-aminobenzoic acid synthase from Streptomyces griseus. J Gen Microbiol 131, 12791287.
  • Graham, C.H., Hawley, T.S., Hawley, R.C., MacDougall, J.R., Kerbel, R.S., Khoo, N. and Lala, P.K. (1993) Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res 206, 2042011.
  • Hamilton-Miller, J.M.T. (1973) Chemistry and biology of the polyene macrolide antibiotics. Bacteriol Rev 37, 166196.
  • Hansen, M.B., Nielsen, S.E. and Berg, K. (1989) Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119, 203210.
  • Hazen, E.L. and Brown, R.F. (1957) Nystatin and method of producing it. USA Patent, 2,797,183.
  • Jonsbu, E. (2001) Production and control of nystatin by Streptomyces noursei. Trondheim, Norway: Norwegian University of Science and Technology.
  • Jonsbu, E., Ellingsen, T.E. and Nielsen, J. (2000) Effects of nitrogen sources on cell growth and production of nystatin by Streptomyces noursei. J Antibiot 53, 13541362.
  • Jonsbu, E., Christensen, B. and Nielsen, J. (2001) Changes of in vivo fluxes through central metabolic pathways during the production of nystatin by Streptomyces noursei in batch culture. Appl Microbiol Biotechnol 56, 93100.
  • Jonsbu, E., McIntyre, M. and Nielsen, J. (2002) The influence of carbon sources and morphology on nystatin production by Streptomyces noursei. J Biotechnol 95, 133144.
  • Juan, F.M. and McDaniel, L.E. (1977) Production of polyene macrolide antibiotics. In Advances in Applied Microbiology, Vol. 21. ed. Perlman, D. pp. 252. New York: Academic Press Inc.
  • Kieser, T., Bibb, M., Buttner, M., Chater, K. and Hopwood, D. (2000) Practical Streptomyces Genetics. Norwich, England: The John Innes Foundation.
  • Komori, T. (1990) Trichomycin B, a polyene macrolide from Streptomyces. J Antibiot 43, 778782.
  • Lemke, A., Kiderlen, A.F. and Kayser, O. (2005) Amphotericin B. Appl Microbiol Biotechnol 68, 151162.
  • Liu, D.M., McDaniel, L.E. and Schaffner, C.P. (1975) Factors affecting the production of candicidin. Antimicrob Agents Chemother 7, 196202.
  • Martin, J.F. and Liras, P. (2010) Engineering of regulatory cascades and networks controlling antibiotic biosynthesis in Streptomyces. Curr Opin Microbiol 13, 263273.
  • Martin, J.F. and McDaniel, L.E. (1977) Production of polyene macrolide antibiotics. In Advances in Applied Microbiology, Vol. 21 ed. Perlman, D. pp. 252. New York: Academic Press Inc.
  • Martin, J., Sola-Landa, A., Santos-Beneit, F., Fernandez-Martinez, L., Prieto, C. and Rodríguez-Garcia, A. (2011) Cross-talk of global nutritional regulators in the control of primary and secondary metabolism in Streptomyces. Microb Biotechnol 4, 165171.
  • McNamara, C.M., Box, S., Crawforth, J.M., Hickman, B.S., Norwood, T.J. and Rawlings, B.J. (1998) Biosynthesis of Amphotericin B. J Chem Soc Perkin Trans 1 1, 8387.
  • Milhaud, J. (1992) Permeabilizing action of filipin III on model membranes through a filipin-phospholipid binding. Biochim Biophys Acta 1105, 307318.
  • Mulks, M.H., Nair, M.G. and Putnam, A.R. (1990) In vitro antibacterial activity of faeriefungin, a new broad-spectrum polyene macrolide antibiotic. Antimicrob Agents Chemother 34, 17621765.
  • Nikodinovic, J (2004) Molecular Genetics of Amphotericin Biosynthesis in Streptomyces nodosus. Sydney, Australia: The University of New South Wales.
  • Olano, C., Lombó, F., Méndez, C. and Salas, J.A. (2008) Improving production of bioactive secondary metabolites in actinomycetes by metabolic engineering. Metab Eng 10, 281292.
  • Omura, S. and Tanaka, H. (1984) Production, structure and antifungal activity of polyene macrolides. In Macrolide Antibiotics: Chemistry, Biology and Practice ed. Omura, S. pp. 351396. London, UK: Academic Press, Inc.
  • Ostrosky-Zeichner, L., Casadevall, A., Galgiani, J.N., Odds, F.C. and Rex, J.H. (2010) An insight into the antifungal pipeline: selected new molecules and beyond. Nat Rev Drug Discov 9, 719727.
  • Recamier, K.S., Hernandez-Gomez, A., Gonzalez-Damian, J. and Ortega-Blake, I. (2010) Effect of membrane structure on the action of polyenes: I. Nystatin action in cholesterol- and ergosterol-containing membranes. J Membr Biol 237, 3140.
  • Rimaroli, C., Bonabello, A., Sala, P. and Bruzzese, T. (2002) Pharmacokinetics and tissue distribution of a new partricin A derivative (N-dimethylaminoacetyl-partricin A 2-dimethylaminoethylamide diaspartate) in mice. J Pharm Sci 91, 12521258.
  • Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
  • Savic, M., Bratic, I. and Vasiljevic, B. (2007) Streptomyces durmitorensis sp. nov., a producer of an FK506-like immunosuppressant. Int J Syst Evol Microbiol 57, 21192124.
  • Schaffner, C. and Kientzler, D. (2000) Process for the production of amphotericin B inhibiting production of amphotericin A. USA Patent, 6132993.
  • Sousa, A.S., Gómez-Criado, C. and Baquero, F. (1985) Susceptibility of Candida spp. of clinical origin to lucknomycin, a new polyenic antibiotic. Chemotherapy 31, 211215.
  • Stodulkova, E., Kuzma, M., Hench, I.B., Cerny, J., Kralova, J., Novak, P., Chudickova, M., Savic, M. et al. (2011) New polyene macrolide family produced by submerged culture of Streptomyces durmitorensis. J Antibiot 64, 717722.
  • Teerlink, T., de Kruijff, B. and Demel, R.A. (1980) The action of pimaricin, etruscomycin and amphotericin B on liposomes with varying sterol content. Biochim Biophys Acta 599, 484492.
  • Vaishnav, P. and Demain, A.L. (2011) Unexpected applications of secondary metabolites. Biotechnol Adv 29, 223229.
  • Van Leeuwen, M.R., Golovina, E.A. and Dijksterhuis, J. (2009) The polyene antimycotics nystatin and filipin disrupt the plasma membrane, whereas natamycin inhibits endocytosis in germinating conidia of Penicillium discolor. J Appl Microbiol 106, 19081918.
  • Vazquez, J.A. (2007) Combination antifungal therapy: the new frontier. Future Microbiol 2, 115139.
  • Wasko, P., Luchowski, R., Tutaj, K., Grudzinski, W., Adamkiewicz, P. and Gruszecki, W.I. (2012) Toward understanding of toxic side effects of a polyene antibiotic amphotericin B: fluorescence spectroscopy reveals widespread formation of the specific supramolecular structures of the drug. Mol Pharm 9, 15111520.
  • Zotchev, S.B. (2003) Polyene macrolide antibiotics and their applications in human therapy. Curr Med Chem 10, 211223.